|
|
| | 1-(4-(4-Amino-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-3-(5-(1-(trifluoromethyl)cyclopropyl)isoxazol-3-yl)urea Basic information |
| | 1-(4-(4-Amino-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-3-(5-(1-(trifluoromethyl)cyclopropyl)isoxazol-3-yl)urea Chemical Properties |
| Boiling point | 614.176±55.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.738±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 12.141±0.70(predicted) | | form | Solid | | color | White to off-white |
| | 1-(4-(4-Amino-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-3-(5-(1-(trifluoromethyl)cyclopropyl)isoxazol-3-yl)urea Usage And Synthesis |
| Uses | Ofirnoflastum (Ofirnoflast) is a serine/ threonine-protein kinase Nek7 inhibitor, with anti inflammatory effect[1]. | | References | [1] Ofirnoflastum (Ofirnoflast). WHO Drug Information, Vol. 37, No. 4, 2023. |
| | 1-(4-(4-Amino-7-cyclopropyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-2-fluorophenyl)-3-(5-(1-(trifluoromethyl)cyclopropyl)isoxazol-3-yl)urea Preparation Products And Raw materials |
|